+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Women's Health Diagnostics Market Size, Share & Trends Analysis Report By End Use, By Application (Cancer, Infectious Disease, Osteoporosis, Pregnancy, Prenatal), and Segment Forecasts, 2018 - 2025

  • ID: 4661562
  • Report
  • September 2018
  • Region: Global
  • 100 pages
  • Grand View Research
1 of 3

FEATURED COMPANIES

  • Abbott
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • MORE
The global women’s health diagnostics market size is expected to reach USD 76.2 billion by 2025. Rising adoption of point-of-care diagnostics and growing incidence of various chronic and lifestyle diseases are among the key factors stimulating the growth of the market. Besides this, introducing various awareness programs is also anticipated to work in favor the market during the forecast period. For instance, in 2014, the European Commission launched joint action for European Guide on Quality Improvement in Comprehensive Cancer Control.

Women’s health diagnostics is witnessing high growth due to increased funding from various organizations. For instance, in May 2015, Abcodia received funding of USD 8.0 million from Cambridge Innovative Capital, Scottish Equity Partners, Albion Ventures, and UCLB to launch Risk of Ovarian Cancer Algorithm (ROCA) test in the U.K. for early detection of ovarian cancer.

On the basis of end use, the market has been bifurcated into hospital & diagnostics centers and home. Hospitals and diagnostic centers accounted for a larger share in the market due to high number of visits to hospitals and more reliable detection.

The market in Asia Pacific is likely to witness significant growth over the coming years. The growth of the market can be attributed to increasing investments in healthcare, growing focus of international device manufacturers on strengthening their distribution networks within the region, and epidemiological shift from infectious diseases to chronic diseases within regional boundaries.

Further key findings from the report suggest:
  • Increasing investments by governments and private bodies and rising disposable income are providing a push to the market
  • Cancer accounted for the highest share in the market in 2017. The segment will register noteworthy growth during the forecast period owing to availability of early detection tests and government initiatives to tackle cancer
  • Prenatal testing is estimated to be the fastest growing segment during the same period owing to rising prevalence of prenatal diseases, increasing maternal age, surging healthcare expenditure, and development of advanced diagnostic tests
  • Geographically, North America was the leading revenue contributor to the women’s health diagnostics market in 2017. It is anticipated to maintain its dominance through 2025, thanks to widening base of diagnostic and imaging centers, mounting cases of cancer, growing awareness about fertility testing, and spiraling adoption of point-of-care testing devices
  • Some of the key players are Siemens Healthcare Private Limited; Hologic, Inc.;GE Healthcare; F. Hoffmann-La Roche Ltd.; bioMérieux SA; Koninklijke Philips N.V; Abbott; Becton, Dickinson and Company, Quest Diagnostics, Inc.; and PerkinElmer, Inc.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • MORE
Chapter 1 Executive Summary
1.1 Market Snapshot

Chapter 2 Research Methodology
2.1 Information Procurement
2.2 Data Analysis

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation and Scope
3.1.1 Market driver analysis
3.1.1.1 Incidence of various chronic and lifestyle disorders in women
3.1.1.2 Increasing adoption of point-of-care diagnostics
3.1.1.3 Increasing number of diagnostic and imaging centers
3.1.1.4 High prevalence of infectious diseases among women
3.1.2 Market restraint analysis
3.1.2.1 Lack of skilled laboratory technicians
3.1.2.2 High cost
3.2 Penetration & Growth Prospects Mapping
3.3 Women’s Health Diagnostics Market - PESTLE Analysis
3.4 Industry Analysis - Porter’s
3.5 Women’s Health Diagnostics Competitive Landscape: Market Position Analysis (Based on Services, Regional Presence, and Recent Updates)

Chapter 4 Women’s Health Diagnostics Market : Application Estimates & Trend Analysis
4.1 Women’s Health Diagnostics Market: Application Analysis
4.2 Cancer Testing
4.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)
4.2.1.1 Breast cancer
4.2.1.2 Cervical cancer
4.2.1.3 Ovarian cancer
4.3 Infectious Disease Testing
4.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.4 Osteoporosis Testing
4.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.5 Pregnancy and Fertility Testing
4.5.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.6 Prenatal Testing
4.6.1. Market estimates and forecast, 2014 - 2025 (USD Million)

Chapter 5 Women’s Health Diagnostics Market : End Use Estimates & Trend Analysis
5.1 Women’s Health Diagnostics Market: End Use Analysis
5.2 Hospital and Diagnostics Centers
5.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)
5.3 Home
5.3.1 Market estimates and forecast, 2014 - 2025 (USD Million)

Chapter 6 Women’s Health Diagnostics Market : Regional Estimates & Trend Analysis
6.1 Women’s health diagnostics market share, By Region, 2014 & 2025
6.2 North America
6.2.1 U.S.
6.2.1.1 Market estimates and forecast, 2014 - 2025 (USD Million)
6.2.2 Canada
6.2.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)
6.3 Europe
6.3.1 U.K.
6.3.1.1 Market estimates and forecast, 2014 - 2025 (USD Million)
6.3.2 Germany
6.3.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Market estimates and forecast, 2014 - 2025 (USD Million)
6.4.2 Japan
6.4.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)
6.4.3 China
6.4.3.1 Market estimates and forecast, 2014 - 2025 (USD Million)
6.5 Latin America
6.5.1 Market estimates and forecast, 2014 - 2025 (USD Million)
6.5.2 Brazil
6.5.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)
6.5.3 Mexico
6.5.3.1 Market estimates and forecast, 2014 - 2025 (USD Million)
6.6 MEA
6.6.1 Market estimates and forecast, 2014 - 2025 (USD Million)
6.6.2 South Africa
6.6.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)

Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Company Profiles
7.2.1 Siemens Healthcare GmBH
7.2.1.1 Company overview
7.2.1.2 Financial performance
7.2.1.3 Product benchmarking
7.2.1.4 Strategic initiatives
7.2.2 Hologic, Inc.
7.2.2.1 Company overview
7.2.2.2 Financial performance
7.2.2.3 Product benchmarking
7.2.2.4 Strategic initiatives
7.2.3 GE Healthcare
7.2.3.1 Company overview
7.2.3.2 Financial performance
7.2.3.3 Product benchmarking
7.2.3.4 Strategic initiatives
7.2.4 F. Hoffmann-La Roche Ltd
7.2.4.1 Company overview
7.2.4.2 Financial performance
7.2.4.3 Product benchmarking
7.2.4.4 Strategic initiatives
7.2.5 bioMérieux SA
7.2.5.1 . Company overview
7.2.5.2 Financial performance
7.2.5.3 Product benchmarking
7.2.5.4 Strategic initiatives
7.2.6 Koninklijke Philips N.V.
7.2.6.1 Company overview
7.2.6.2 Financial performance
7.2.6.3 Product benchmarking
7.2.6.4 Strategic initiatives
7.2.7 Abbott
7.2.7.1 Company overview
7.2.7.2 Financial performance
7.2.7.3 Product benchmarking
7.2.7.4 Strategic initiatives
7.2.8 Becton, Dickinson and Company
7.2.8.1 Company overview
7.2.8.2 Financial performance
7.2.8.3 Product benchmarking
7.2.8.4 Strategic initiatives
7.2.9 Quest Diagnostics, Inc.
7.2.9.1 Company overview
7.2.9.2 Financial performance
7.2.9.3 Product benchmarking
7.2.9.4 Strategic initiatives
7.2.10 PerkinElmer, Inc.
7.2.10.1 Company overview
7.2.10.2 Financial performance
7.2.10.3 Product benchmarking
7.2.10.4 Strategic initiatives

List of Tables

Table 1 North America women’s health diagnostics, by country, 2014 - 2025 (USD Million)
Table 2 North America women’s health diagnostics, by application, 2014 - 2025 (USD Million)
Table 3 North America cancer testing women’s health diagnostics, by application, 2014 - 2025 (USD Million)
Table 4 U.S. women’s health diagnostics market, by application, 2014 - 2025 (USD Million)
Table 5 U.S. cancer testing women’s health diagnostics, by application, 2014 - 2025 (USD Million)
Table 6 U.S. women’s health diagnostics market, by end use, 2014 - 2025 (USD Million)
Table 7 Canada women’s health diagnostics market, by application, 2014 - 2025 (USD Million)
Table 8 Canada cancer testing women’s health diagnostics, by application, 2014 - 2025 (USD Million)
Table 9 Canada women’s health diagnostics market, by end use, 2014 - 2025 (USD Million)
Table 10 Europe women’s health diagnostics market, by country, 2014 - 2025 (USD Million)
Table 11 Europe women’s health diagnostics market, by application, 2014 - 2025 (USD Million)
Table 12 Europe cancer testing women’s health diagnostics, by application, 2014 - 2025 (USD Million)
Table 13 Europe women’s health diagnostics market, by end use, 2014 - 2025 (USD Million)
Table 14 U.K. women’s health diagnostics market, by application, 2014 - 2025 (USD Million)
Table 15 U.K. cancer testing women’s health diagnostics, by application, 2014 - 2025 (USD Million)
Table 16 U.K. women’s health diagnostics market, by end use, 2014 - 2025 (USD Million)
Table 17 Germany women’s health diagnostics market, by application, 2014 - 2025 (USD Million)
Table 18 Germany cancer testing women’s health diagnostics, by application, 2014 - 2025 (USD Million)
Table 19 Germany women’s health diagnostics market, by end use, 2014 - 2025 (USD Million)
Table 20 Countries in the economic and social commission for Asia and the Pacific (ESCAP) region with National Legislation on aging
Table 21 Asia Pacific women’s health diagnostics market, by country, 2014 - 2025 (USD Million)
Table 22 Asia Pacific women’s health diagnostics market, by application, 2014 - 2025 (USD Million)
Table 23 Asia Pacific cancer testing women’s health diagnostics, by application, 2014 - 2025 (USD Million)
Table 24 Asia Pacific women’s health diagnostics market, by end use, 2014 - 2025 (USD Million)
Table 25 Japan women’s health diagnostics market, by application, 2014 - 2025 (USD Million)
Table 26 Japan cancer testing women’s health diagnostics, by application, 2014 - 2025 (USD Million)
Table 27 Japan women’s health diagnostics market, by end use, 2014 - 2025 (USD Million)
Table 28 China women’s health diagnostics market, by application, 2014 - 2025 (USD Million)
Table 29 China cancer testing women’s health diagnostics, by application, 2014 - 2025 (USD Million)
Table 30 China women’s health diagnostics market, by end use, 2014 - 2025 (USD Million)
Table 31 Latin America women’s health diagnostics market, by country, 2014 - 2025 (USD Million )
Table 32 Latin America women’s health diagnostics market, by application, 2014 - 2025 (USD Million)
Table 33 Latin America cancer testing women’s health diagnostics, by application, 2014 - 2025 (USD Million)
Table 34 Latin America women’s health diagnostics market, by end use, 2014 - 2025 (USD Million)
Table 35 Brazil women’s health diagnostics market, by application, 2014 - 2025 (USD Million)
Table 36 Brazil cancer testing women’s health diagnostics, by application, 2014 - 2025 (USD Million)
Table 37 Brazil women’s health diagnostics market, by end use, 2014 - 2025 (USD Million)
Table 38 Mexico women’s health diagnostics market, by application, 2014 - 2025 (USD Million)
Table 39 Mexico cancer testing women’s health diagnostics, by application, 2014 - 2025 (USD Million)
Table 40 Mexico women’s health diagnostics market, by end use, 2014 - 2025 (USD Million)
Table 41 MEA women’s health diagnostics market, by country, 2014 - 2025 (USD Million)
Table 42 MEA women’s health diagnostics market, by application, 2014 - 2025 (USD Million)
Table 43 MEA cancer testing women’s health diagnostics, by application, 2014 - 2025 (USD Million)
Table 44 MEA women’s health diagnostics market, by end use, 2014 - 2025 (USD Million)
Table 45 South Africa women’s health diagnostics market, by application, 2014 - 2025 (USD Million)
Table 46 South Africa cancer testing women’s health diagnostics, by application, 2014 - 2025 (USD Million)
Table 47 South Africa women’s health diagnostics market, by end use, 2014 - 2025 (USD Million)

List of Figures

FIG. 1 Market summary 2016, (USD Million)
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Leading cause of death for women in the world, 2011
FIG. 12 Increasing prevalence of chronic diseases, 1995 - 2030 (Million)
FIG. 13 Market restraint relevance analysis (Current & future impact)
FIG. 14 Costs of diagnostic test in U.S.
FIG. 15 Penetration & growth prospect mapping
FIG. 16 Women’s health diagnostics market - PESTLE analysis
FIG. 17 Porter’s five forces analysis
FIG. 18 Women’s health diagnostics competitive landscape: Market position analysis (based on products, regional presence)
FIG. 19 Women’s health diagnostics market, Application outlook: Key takeaways
FIG. 20 Women’s health diagnostics market: Application movement analysis
FIG. 21 Cancer market, 2014 - 2025 (USD Million)
FIG. 22 Estimated New Female Breast Cancer Cases and Deaths by Age, in US, 2015
FIG. 23 Number of women screened through the NBCCEDP by program year July 2011 to June 2016
FIG. 24 Reimbursement scenario for breast cancer diagnostics, 2017
FIG. 25 Breast cancer market, 2014 - 2025 (USD Million)
FIG. 26 Medicaid spending among beneficiaries with cervical cancer among females, in Texas, 2014
FIG. 27 Cervical cancer market, 2014 - 2025 (USD Million)
FIG. 28 Ovarian cancer market, 2014 - 2025 (USD Million)
FIG. 29 All reporTable infectious disease incidence rates, Durham and Ontario, 2010-2015
FIG. 30 Infectious disease testing market, 2014 - 2025 (USD Million)
FIG. 31 Osteoporosis testing market, 2014 - 2025 (USD Million)
FIG. 32 Pregnancy and fertility testing market, 2014 - 2025 (USD Million)
FIG. 33 Change in prevalence of Down syndrome and Trisomy conditions in 9 states (Arkansas, Colorado, Georgia, Iowa, North Carolina, Oklahoma, Puerto Rico, Texas and Utah)
FIG. 34 Prenatal testing market, 2014 - 2025 (USD Million)
FIG. 35 Women’s health diagnostics market: End use movement analysis
FIG. 36 Hospital and diagnostics centers market, 2014 - 2025 (USD Million)
FIG. 37 Home market, 2014 - 2025 (USD Million)
FIG. 38 Regional market place: Key takeaways
FIG. 39 Women’s health diagnostics market: Regional outlook, 2014 & 2025
FIG. 40 North America women’s health diagnostics market, 2014 - 2025 (USD Million)
FIG. 41 U.S. women’s health diagnostics market, 2014 - 2025 (USD Million)
FIG. 42 Canada women’s health diagnostics market, 2014 - 2025 (USD Million)
FIG. 43 Europe women’s health diagnostics market, 2014 - 2025 (USD Million)
FIG. 44 U.K. women’s health diagnostics market, 2014 - 2025 (USD Million)
FIG. 45 Germany women’s health diagnostics market, 2014 - 2025 (USD Million)
FIG. 46 Asia Pacific women’s health diagnostics market, 2014 - 2025 (USD Million)
FIG. 47 Japan women’s health diagnostics market, 2014 - 2025 (USD Million)
FIG. 48 China Women’s Health Diagnostics Market, 2014 - 2025 (USD Million)
FIG. 49 Latin America women’s health diagnostics market, 2014 - 2025 (USD Million)
FIG. 50 Brazil women’s health diagnostics market, 2014 - 2025 (USD Million)
FIG. 51 Mexico women’s health diagnostics market, 2014 - 2025 (USD Million)
FIG. 52 MEA women’s health diagnostics market, 2014 - 2025 (USD Million)
FIG. 53 South Africa women’s health diagnostics market, 2014 - 2025 (USD Million)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Siemens Healthcare GmBH
  • Hologic, Inc.
  • GE Healthcare
  • F. Hoffmann-La Roche Ltd
  • bioMérieux SA
  • Koninklijke Philips N.V.
  • Abbott
  • Becton, Dickinson and Company
  • Quest Diagnostics, Inc.
  • PerkinElmer, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll